Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens
- 13 August 2011
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 249 (10) , 1547-1552
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical and histological findings after intravitreal injection of bevacizumab (Avastin®) in a porcine model of choroidal neovascularizationActa Ophthalmologica, 2010
- Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucomaActa Ophthalmologica, 2010
- Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumabBritish Journal of Ophthalmology, 2009
- Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusionBritish Journal of Ophthalmology, 2008
- Penetration of Bevacizumab through the Retina after Intravitreal Injection in the MonkeyInvestigative Ophthalmology & Visual Science, 2007
- Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)British Journal of Ophthalmology, 2006
- Short‐term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucomaActa Ophthalmologica Scandinavica, 2006
- Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Diabetic iris neovascularization. Natural history and treatmentActa Ophthalmologica Scandinavica, 1997
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989